4.2 Article

Generation of a human CDX2 knock-in reporter iPSC line (MHHi007-A-1) to model human trophoblast differentiation

Journal

STEM CELL RESEARCH
Volume 30, Issue -, Pages 117-121

Publisher

ELSEVIER
DOI: 10.1016/j.scr.2018.05.015

Keywords

-

Funding

  1. German Research Foundation, Cluster of Excellence REBIRTH [DFG EXC62/3]

Ask authors/readers for more resources

Caudal-type homeobox 2 (CDX2) transcription factor is an important marker for early trophoblast lineages and intestinal epithelium. Due to its nuclear expression the immunostaining and sorting of viable CDX2(pos) cells is not possible. In this paper we report the generation and describe key characteristics of a CDX2(Venus) knock-in reporter hiPSC-cell line (MHHi007-A-1) which can serve as an in vitro tool to study human trophoblast and intestinal differentiation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification

Mania Ackermann, Kathrin Haake, Henning Kempf, Paul Kaschutnig, Anna-Carina Weiss, Ariane H. H. Nguyen, Markus Abeln, Sylvia Merkert, Mark Phillip Kuhnel, Dorothee Hartmann, Danny Jonigk, Thomas Thum, Andreas Kispert, Michael D. Milsom, Nico Lachmann

Summary: Embryonic hematopoietic development was successfully simulated using a 3D cell culture system, revealing the crucial role of interleukin 3 (IL-3) in the transition of hemato-endothelial progenitors to hematopoietic cells.

HAEMATOLOGICA (2021)

Article Cell & Tissue Engineering

Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing

S. Merkert, M-C Jaboreck, L. Engels, M. N. H. Malik, G. Goehring, F. Pessler, U. Martin, R. Olmer

Summary: ISG15 is a highly upregulated protein in response to viral infection, and its deficiency can lead to type I interferonopathy while enhancing antiviral protection. Generating ISG15 knockout clones from human iPSCs provides valuable cell resources for studying ISG15 deficiency mechanisms and gaining deeper insights into its biological function.

STEM CELL RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Human heart-forming organoids recapitulate early heart and foregut development

Lika Drakhlis, Santoshi Biswanath, Clara-Milena Farr, Victoria Lupanow, Jana Teske, Katharina Ritzenhoff, Annika Franke, Felix Manstein, Emiliano Bolesani, Henning Kempf, Simone Liebscher, Katja Schenke-Layland, Jan Hegermann, Lena Nolte, Heiko Meyer, Jeanne de la Roche, Stefan Thiemann, Christian Wahl-Schott, Ulrich Martin, Robert Zweigerdt

Summary: This study successfully generated three-dimensional heart-forming organoids that closely resemble early native heart anlagen, containing myocardial layer, endocardial-like cells, septum-transversum-like anlagen, and distinct anterior versus posterior foregut endoderm tissues. These organoids were used to study genetic defects in vitro and demonstrated a phenotype similar to cardiac malformations seen in transgenic mice with the knockout of NKX2.5 gene.

NATURE BIOTECHNOLOGY (2021)

Article Biochemical Research Methods

Production and cryopreservation of definitive endoderm from human pluripotent stem cells under defined and scalable culture conditions

Anais Sahabian, Julia Dahlmann, Ulrich Martin, Ruth Olmer

Summary: The protocol described a detailed method for large-scale production of definitive endoderm (DE) cells from human pluripotent stem cells (hPSCs) with high purity. By using chemically defined and xeno-free media, a significant number of DE cells can be efficiently generated within a short period of time for downstream differentiation and research purposes.

NATURE PROTOCOLS (2021)

Article Cell & Tissue Engineering

High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling

Felix Manstein, Kevin Ullmann, Christina Kropp, Caroline Halloin, Wiebke Triebert, Annika Franke, Clara-Milena Farr, Anais Sahabian, Alexandra Haase, Yannik Breitkreuz, Michael Peitz, Oliver Brustle, Stefan Kalies, Ulrich Martin, Ruth Olmer, Robert Zweigerdt

Summary: By combining STBR technology with in silico process modeling, challenges in hPSC production were overcome, leading to a rapid 70-fold increase in cell expansion and maintenance of cell quality stability.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

An early cell shape transition drives evolutionary expansion of the human forebrain

Silvia Benito-Kwiecinski, Stefano L. Giandomenico, Magdalena Sutcliffe, Erlend S. Riis, Paula Freire-Pritchett, Iva Kelava, Stephanie Wunderlich, Ulrich Martin, Gregory A. Wray, Kate McDole, Madeline A. Lancaster

Summary: Research shows that neuroepithelial cell shape in apes is a protracted process, while human brain organoids are larger due to a delay in this transition. RNA sequencing reveals differences in expression dynamics of cell morphogenesis factors, including ZEB2.
Article Cell & Tissue Engineering

Generation of human induced pluripotent stem cell lines encoding for genetically encoded calcium indicators RCaMP1h and GCaMP6f

Maria Elena Ricci Signorini, Monika Szepes, Anna Melchert, Mine Bakar, Sylvia Merkert, Alexandra Haase, Gudrun Gohring, Ulrich Martin, Ina Gruh

Summary: Calcium plays a crucial role in cardiomyocytes, translating electrical signals into contraction forces. A non-invasive fluorescence imaging technique allows for the monitoring of calcium changes in human induced pluripotent stem cell-derived cardiomyocytes, providing insights into cardiac electrophysiology in vitro and in vivo. Genetically encoded calcium indicators have been successfully introduced into a well-established hiPSC line, enabling the monitoring of calcium handling in highly pure populations of hiPSC-CMs.

STEM CELL RESEARCH (2022)

Article Medicine, Research & Experimental

Targeted biallelic integration of an inducible Caspase 9 suicide gene in iPSCs for safer therapies

Stephanie Wunderlich, Alexandra Haase, Sylvia Merkert, Kirsten Jahn, Maximillian Deest, Helge Frieling, Silke Glage, Wilhelm Korte, Andreas Martens, Andreas Kirschning, Andre Zeug, Evgeni Ponimaskin, Gudrun Goehring, Mania Ackermann, Nico Lachmann, Thomas Moritz, Robert Zweigerdt, Ulrich Martin

Summary: Drug-inducible suicide systems can help reduce the risk of drug-resistant subclones in hiPSC therapies, but rare drug-resistant subclones can still appear in monoallelic iCASP9 hiPSCs both in vitro and in vivo.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)

Article Oncology

ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives

Syed Fakhar-ul-Hassnain Waqas, Aaqib Sohail, Ariane Hai Ha Nguyen, Abdulai Usman, Tobias Ludwig, Andre Wegner, Muhammad Nasir Hayat Malik, Sven Schuchardt, Robert Geffers, Moritz Winterhoff, Sylvia Merkert, Ulrich Martin, Ruth Olmer, Nico Lachmann, Frank Pessler

Summary: This study developed induced pluripotent stem cell-derived macrophages and endothelial cells as a model to study the cellular phenotype of ISG15 deficiency and identify novel treatments. The researchers found that ISG15 deficiency resulted in a multifaceted pathological phenotype, including increased inflammation, propensity for cell death, and oxidative stress. Treatment with itaconate, dimethyl-itaconate, 4-octyl-itaconate, and the JAK1/2 inhibitor ruxolitinib improved cellular function and gene expression, suggesting their potential as therapeutics for this rare disorder.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Cell & Tissue Engineering

Generation of two TMEM16A knockout iPSC clones each from a healthy human iPSC line, from a Cystic Fibrosis patient specific line with p. Phe508del mutation and from the gene corrected iPSC line

Mark-Christian Jaboreck, Jonathan Lukas Luehmann, Mia Mielenz, Frauke Stanke, Gudrun Goehring, Ulrich Martin, Ruth Olmer, Sylvia Merkert

Summary: In this study, knockout cell lines lacking the TMEM16A gene were generated using CRISPR/Cas9 technology in both healthy human induced pluripotent stem cells (iPSCs) and cystic fibrosis patient iPSCs. These cell lines can provide insights into the role of TMEM16A in mucus secretion and production, as well as evaluating its therapeutic potential.

STEM CELL RESEARCH (2022)

Article Cell & Tissue Engineering

Generation of two human NRF2 knockout iPSC clones using CRISPR/Cas9 editing

Sylvia Merkert, Alexandra Haase, Julia Dahlmann, Gudrun Goehring, Fakhar H. Waqas, Frank Pessler, Ulrich Martin, Ruth Olmer

Summary: The nuclear factor erythroid 2-related factor 2 (NRF2) plays a role in regulating antioxidative and anti-inflammatory proteins. By using CRISPR/Cas9 editing, NRF2 was eliminated in the human iPS cell line MHHi001-A, resulting in two NRF2 knockout iPSC clones MHHi001-A-6 and MHHi001-A-7. These cells can be differentiated into epithelial or endothelial cells to investigate the antiviral effects of molecules activating the NRF2 signaling pathway.

STEM CELL RESEARCH (2023)

Article Cell Biology

Primary Ciliary Dyskinesia Patient-Specific hiPSC-Derived Airway Epithelium in Air-Liquid Interface Culture Recapitulates Disease Specific Phenotypes In Vitro

Laura von Schledorn, David Puertollano Martin, Nicole Cleve, Janina Zoellner, Doris Roth, Ben Ole Staar, Jan Hegermann, Felix C. Ringshausen, Janna Nawroth, Ulrich Martin, Ruth Olmer

Summary: Primary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the function of motile cilia in the respiratory tract, leading to chronic inflammation and lung damage. Current treatment options for PCD are only symptomatic, highlighting the need for curative therapies. In this study, researchers developed an in vitro model using human induced pluripotent stem cells (hiPSC) to recapitulate the diseased phenotype of PCD at the molecular, structural, and functional levels.

CELLS (2023)

Article Cell Biology

An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders

Ian O. Shum, Sylvia Merkert, Svitlana Malysheva, Kirsten Jahn, Nico Lachmann, Murielle Verboom, Helge Frieling, Michael Hallensleben, Ulrich Martin

Summary: Abnormalities during trophoblast development can lead to pregnancy-related complications, but the underlying mechanisms are established during the first trimester. Human pluripotent stem cell (hPSC) technology provides a renewable source of cells for studying these diseases. By optimizing the treatment protocol, we were able to generate trophoblast cells enriched for HLA-G(pos) EVT-like cells, which will aid in understanding placenta-related disorders and investigation of immune tolerance towards the fetus.

CELLS (2023)

Article Medicine, Research & Experimental

Congenital deficiency reveals critical role of ISG15 in skin homeostasis

Muhammad Nasir Hayat Malik, Syed Fakhar-ul-Hassnain Waqas, Jana Zeitvogel, Jingyuan Cheng, Robert Geffers, Zeinab Abu-Elbaha Gouda, Ahmed Mahrous Elsaman, Ahmed R. Radwan, Matthias Schefzyk, Peter Braubach, Bernd Auber, Ruth Olmer, Mathias Musken, Lennart M. Roesner, Gisa Gerold, Sven Schuchardt, Sylvia Merkert, Ulrich Martin, Felix Meissner, Thomas Werfel, Frank Pessler

Summary: Ulcerating skin lesions are manifestations of human ISG15 deficiency. Chronic inflammation may not be the sole cause. Two siblings with ISG15 gene mutation were found to have recurrent skin ulcers that healed with scar formation after corticosteroid treatment. ISG15-deficient cells were found to impact cell migration and maintenance of cellular and tissue integrity.

JOURNAL OF CLINICAL INVESTIGATION (2022)

No Data Available